Squarepoint’s Guardant Health GH Stock Holding History

Squarepoint’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41M	Buy	+29,400	New	+$3.2M	﹤0.01%	1688
2026 Q1	–	Sell	-21,800	Closed	-$2.23M	–	4517
2025 Q4	$2.23M	Sell	21,800 -9,000	-29%	-$805K	﹤0.01%	1983
2025 Q3	$1.92M	Buy	30,800 +24,300	+374%	+$1.32M	﹤0.01%	2146
2025 Q2	$338K	Buy	6,500 +700	+12%	+$31.3K	﹤0.01%	3597
2025 Q1	$247K	Sell	5,800 -5,100	-47%	-$220K	﹤0.01%	3881
2024 Q4	$333K	Buy	+10,900	New	+$307K	﹤0.01%	4075
2022 Q1	–	Sell	-4,300	Closed	-$430K	–	3105
2021 Q4	$430K	Hold	4,300	–	–	﹤0.01%	2237
2021 Q3	$538K	Sell	4,300 -14,700	-77%	-$1.75M	﹤0.01%	1912
2021 Q2	$2.36M	Hold	19,000	–	–	0.01%	1089
2021 Q1	$2.9M	Buy	+19,000	New	+$2.87M	0.02%	884

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Squarepoint's GH Position: Q2 2026 in Review

Squarepoint increased its Guardant Health (GH) stake by 203% in Q2 2026, buying an estimated $42.2M and bringing the position to 580,133 shares worth $87M. The position accounts for 0.1% of the portfolio, ranked #199.

Squarepoint first reported a position in GH in Q2 2019 and has held it in 18 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Squarepoint held 580,133 shares of Guardant Health worth $87M as of Q2 2026.
Squarepoint bought 388,393 Guardant Health shares in Q2 2026, an estimated $42.2M.
Guardant Health made up 0.1% of Squarepoint's portfolio in Q2 2026, its #199 holding.
Squarepoint first reported a position in Guardant Health in Q2 2019 and has held it in 18 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.